Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8693325 | 1.00 | POLB (0.37) | POLBTSHRSMN1; SMN2 | |
| Upenazime SCHEMBL1477985 | 0.95 | POLB (0.37) | POLBTSHRSMN1; SMN2 | |
| SCHEMBL15144439 | 0.93 | POLB (0.36) | POLBTSHRSMN1; SMN2 | |
| SCHEMBL15135657 | 0.93 | POLB (0.36) | POLBTSHRSMN1; SMN2 | |
| SCHEMBL7118056 | 0.92 | POLB (0.33) | POLB | |
| SCHEMBL7118054 | 0.92 | POLB (0.33) | POLB | |
| SCHEMBL26537222 | 0.89 | POLB (0.34) | POLBTSHR | |
| SCHEMBL7121165 | 0.88 | POLB (0.35) | POLB | |
| SCHEMBL8362134 | 0.87 | POLB (0.33) | POLBTSHR | |
| SCHEMBL8362130 | 0.87 | POLB (0.33) | POLBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250019418-A1 | SYSTEMS AND METHODS FOR THE PRODUCTION OF METHEMOGLOBIN AND ITS DERIVATIVES | OHIO STATE INNOVATION FOUNDATION | 2025-01-16 | — | — | US | disclosed |
| CN-111225679-B | Novel peptide-based cancer imaging agents | 俄亥俄州创新基金会 | 2024-03-29 | — | — | CN | disclosed |
| US-20230338584-A1 | NOVEL PEPTIDE-BASED CANCER IMAGING AGENTS | OHIO STATE INNOVATION FOUNDATION | 2023-10-26 | — | — | US | disclosed |
| WO-2023086152-A1 | SYSTEMS AND METHODS FOR THE PRODUCTION OF METHEMOGLOBIN AND ITS DERIVATIVES | OHIO STATE INNOVATION FOUNDATION (US) | 2023-05-19 | — | — | WO | disclosed |
| US-11419951-B2 | Peptide-based cancer imaging agents | OHIO STATE INNOVATION FOUNDATION (US) | 2022-08-23 | — | — | US | disclosed |
| US-20220218834-A1 | APOHEMOGLOBIN-HAPTOGLOBIN COMPLEXES AND METHODS OF USING THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-07-14 | — | — | US | disclosed |
| US-11358982-B2 | Methods for the iodination of biomolecules | OHIO STATE INNOVATION FOUNDATION (US) | 2022-06-14 | — | — | US | disclosed |
| EP-3972646-A1 | APOHEMOGLOBIN-HAPTOGLOBIN COMPLEXES AND METHODS OF USING THEREOF | Ohio State Innovation Foundation (US) | 2022-03-30 | — | — | EP | disclosed |
| US-5776894-A | Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors | NOVARTIS AG (CH) | 1998-07-07 | — | — | US | disclosed |
| US-5753627-A | Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis | NOVARTIS AG (CH) | 1998-05-19 | — | — | US | disclosed |
| EP-0515313-A2 | Somatostatin analogues containing chelating groups and their radiolabeled compositions | SANDOZ LTD. (CH) | 1992-11-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250019418-A1 | SYSTEMS AND METHODS FOR THE PRODUCTION OF METHEMOGLOBIN AND ITS DERIVATIVES | MB, HMBS, HCCS | POLB 1439/4885TSHR 1966/4885SMN1; SMN2 1093/4885 |
| US-11358982-B2 | Methods for the iodination of biomolecules | TPO, LPO, MPO | POLB 1053/4885TSHR 100/4885SMN1; SMN2 4273/4885 |
| US-20220218834-A1 | APOHEMOGLOBIN-HAPTOGLOBIN COMPLEXES AND METHODS OF USING THEREOF | HBG1, HBG2, LPO | POLB 1274/4885TSHR 4182/4885SMN1; SMN2 4336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.